# A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

> **NCT04867200** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 60 (estimated)

## Conditions studied

- Anticoagulant

## Interventions

- **DRUG:** Lixiana(D006)
- **DRUG:** CKD-344

## Key facts

- **NCT ID:** NCT04867200
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-27
- **Primary completion:** 2021-05-25
- **Final completion:** 2021-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867200, "A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04867200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*